Castle Biosciences, Inc. (CSTL)
29.57
-2.31
(-7.25%)
USD |
NASDAQ |
Feb 27, 16:00
29.53
-0.04
(-0.14%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (TTM) : 51.50M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Delcath Systems, Inc. | 29.25M |
| Assertio Holdings, Inc. | 2.49M |
| CorMedix, Inc. | 12.46M |
| Harmony Biosciences Holdings, Inc. | 189.59M |